Thematic Review Series The Pathogenesis Of Atherosclerosis. An Interpretive History Of The Cholesterol Controversy, Part III Mechanistically Defining The Role Of Hyperlipidemia

This article is part three of a historical review that examines why it took so long for doctors to accept and treat high cholesterol as a major cause of heart disease. The author, Dr. Daniel Steinberg, argues that solid evidence linking high cholesterol to atherosclerosis (hardening of the arteries) existed over 100 years ago and was strong enough 40 years ago to warrant action, yet most doctors didn't take it seriously until the 1990s.

The review reveals striking statistics about medical practice in the 1980s: nearly half of internal medicine doctors didn't recommend any treatment for high cholesterol unless it was over 300 mg/dl (today's guidelines suggest treatment often begins around 190-200 mg/dl). More than 40% wouldn't prescribe cholesterol-lowering drugs unless levels exceeded 340 mg/dl, and 27% said they never recommended drug treatment at all. This resistance persisted even after the National Institutes of Health officially endorsed cholesterol treatment in 1984.

Dr. Steinberg suggests that one key reason for this delayed acceptance was the lack of a clear, detailed explanation of exactly how high cholesterol damages artery walls. Without understanding the biological mechanisms connecting cholesterol levels to heart disease, many physicians remained skeptical. It wasn't until advances in understanding fat metabolism in the 1950s-60s and cellular biology in the 1970s that the medical community developed a clear picture of how cholesterol contributes to atherosclerosis.

This historical perspective helps explain why cholesterol management became a cornerstone of modern preventive medicine relatively recently, and underscores how scientific evidence must be coupled with mechanistic understanding to drive clinical practice changes that protect patient health.